VENCLAXTA 100 mg Tablet contains Venetoclax 100 mg. It is an anticancer medicine belonging to the class of BCL-2 inhibitors. It works by blocking the BCL-2 protein, which helps cancer cells survive. By inhibiting this protein, Venetoclax promotes the death of abnormal cancer cells.
Uses:
Treatment of certain blood cancers, including:
Chronic lymphocytic leukemia (CLL)
Small lymphocytic lymphoma (SLL)
Acute myeloid leukemia (AML) in combination with other medicines as prescribed by an oncologist
Helps control the growth and survival of abnormal blood cancer cells.
Dose:
Adults: Dose depends on the type of cancer, treatment combination, and patient's response; prescribed by a specialist physician.
Usually started with a gradual dose escalation (ramp-up schedule) to reduce the risk of tumor lysis syndrome.
Take the tablet exactly as directed by the doctor.
Swallow the tablet whole with water; do not crush, chew, or break unless advised.
Take with food as instructed.
Regular monitoring of blood counts, kidney function, and other laboratory tests is required.
Do not stop or change the dose without medical advice.